FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Schleuning

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Daniel Wolff; Francis Ayuk; Hartmut Bertz; Matthias Edinger; Ahmet Elmaagacli; Armin Gerbitz; Jörg Halter; Gerhard C Hildebrandt; Inken Hilgendorf; Ernst Holler; Stephan Klein; Anita Lawitschka; Ralf-Georg Meyer; Sabine Mousset; Michael Schleuning; Hildegard T Greinix
Current Practice in Diagnosis and Treatment of Acute Graft-versus-Host Disease: Results from a Survey among German-Austrian-Swiss Hematopoietic Stem Cell Transplant Centers.
Tim Pfeiffer; Christof Scheid; Michael Schleuning; Günter Schlimok; Susanne Schnittger; Karsten Spiekermann; Johanna Tischer; Jan Braess; Stefanie Buchholz; Gesine Bug; Donald Bunjes; Maximilian Christopeit; Arnold Ganser; Hildegard Greinix; Karl-Heinz Haude; Ernst Holler; Hans-Jochem Kolb; Jiri Mayer; Ralf G Meyer; Christoph Schmid
Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse.
Christoph Schmid; Michael Schleuning; Marcus Hentrich; G E Markl; Armin Gerbitz; Johanna Tischer; Georg Ledderose; D Oruzio; Wolfgang Hiddemann; Hans-Jochem Kolb
High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Schleuning (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Daniel Wolff; Francis Ayuk; Hartmut Bertz; Matthias Edinger; Ahmet Elmaagacli; Armin Gerbitz; Jörg Halter; Gerhard C Hildebrandt; Inken Hilgendorf; Ernst Holler; Stephan Klein; Anita Lawitschka; Ralf-Georg Meyer; Sabine Mousset; Michael Schleuning; Hildegard T Greinix
Current Practice in Diagnosis and Treatment of Acute Graft-versus-Host Disease: Results from a Survey among German-Austrian-Swiss Hematopoietic Stem Cell Transplant Centers.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(5):767-76.
2013: Tim Pfeiffer; Christof Scheid; Michael Schleuning; Günter Schlimok; Susanne Schnittger; Karsten Spiekermann; Johanna Tischer; Jan Braess; Stefanie Buchholz; Gesine Bug; Donald Bunjes; Maximilian Christopeit; Arnold Ganser; Hildegard Greinix; Karl-Heinz Haude; Ernst Holler; Hans-Jochem Kolb; Jiri Mayer; Ralf G Meyer; Christoph Schmid
Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse.
Haematologica 2013;98(4):518-25.
2008: Christoph Schmid; Michael Schleuning; Marcus Hentrich; G E Markl; Armin Gerbitz; Johanna Tischer; Georg Ledderose; D Oruzio; Wolfgang Hiddemann; Hans-Jochem Kolb
High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission.
Bone marrow transplantation 2008;41(8):721-7.
2007: Martin Weisser; Michael Schleuning; Claudia Haferlach; Rainer Schwerdtfeger; Hans-Jochem Kolb
Allogeneic stem-cell transplantation provides excellent results in advanced stage chronic myeloid leukemia with major cytogenetic response to pre-transplant imatinib therapy.
Leukemia & lymphoma 2007;48(2):295-301.
2006: Christoph Schmid; Michael Schleuning; Rainer Schwerdtfeger; Bernd Hertenstein; Eva Mischak-Weissinger; Donald Bunjes; Stephanie von Harsdorf; Christoph Scheid; Udo Holtick; Hildegard Greinix; Felix Keil; Barbara Schneider; Michael Sandherr; Gesine Bug; Johanna Tischer; Georg Ledderose; Michael Hallek; Wolfgang Hiddemann; Hans-Jochem Kolb
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation.
Blood 2006;108(3):1092-9.
2006: Michael W N Deininger; Michael Schleuning; Hilde Greinix; Herbert G Sayer; Thomas Fischer; Jesus Martinez; Richard T Maziarz; Eduardo Olavarria; Leo Verdonck; Kerstin Schaefer; Conxa Boqué; Edgar Faber; Arnon Nagler; Enrico Pogliani; Nigel Russell; Liisa Volin; Urs Schanz; Gottfried Doelken; Michael Kiehl; Axel A Fauser; Brian J Druker; Anna Sureda; Simona Iacobelli; Ronald Brand; Rainer Krahl; Thoralf Lange; Andreas Hochhaus; Alois Gratwohl; Hans Kolb; Dietger Niederwieser
The effect of prior exposure to imatinib on transplant-related mortality.
Haematologica 2006;91(4):452-9.
2005: Christoph Schmid; Michael Schleuning; Georg Ledderose; Johanna Tischer; Hans-Jochem Kolb
Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5675-87.
2005: Marcus Hentrich; Daniel Oruzio; Gabriele Jäger; Marcus Schlemmer; Michael Schleuning; Xaver Schiel; Wolfgang Hiddemann; Hans-Jochem Kolb
Impact of human herpesvirus-6 after haematopoietic stem cell transplantation.
British journal of haematology 2005;128(1):66-72.
2004: Martin Weisser; Michael Schleuning; Georg Ledderose; Burkhard Rolf; Susanne Schnittger; Claudia Schoch; Rainer Schwerdtfeger; Hans-Jochem Kolb
Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease.
Bone marrow transplantation 2004;34(12):1083-8.
2004: C Scheinkönig; S Kappicht; Hans-Jochem Kolb; Michael Schleuning
Adoption of long-term cultures to evaluate the cryoprotective potential of trehalose for freezing hematopoietic stem cells.
Bone marrow transplantation 2004;34(6):531-6.
2004: C Schmid; Michael Schleuning; J Aschan; O Ringdén; J Hahn; Ernst Holler; U Hegenbart; Dietger Niederwieser; M Dugas; Georg Ledderose; Hans-Jochem Kolb
Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation.
Leukemia 2004;18(8):1430-3.
2004: Michael Schleuning; Harald Buxbaum-Conradi; Gabriele Jäger; Hans-Jochem Kolb
Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(2):135-44.
2003: Axel R Zander; Nicolaus Kröger; Michael Schleuning; J Finke; Tatjana Zabelina; Dietrich W Beelen; Rainer Schwerdtfeger; H Baurmann; Martin Bornhäuser; Gerhard Ehninger; Axel A Fauser; Michael Kiehl; Rudolf Trenschel; Hellmut D Ottinger; H Bertz; J Berger; Hans-Jochem Kolb; Ulrich W Schaefer
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML).
Bone marrow transplantation 2003;32(4):355-61.
2003: Michael Schleuning; W Günther; Johanna Tischer; Georg Ledderose; Hans-Jochem Kolb
Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML.
Bone marrow transplantation 2003;32(3):243-50.
2003: Hans-Jochem Kolb; Wolfgang Guenther; Boglarka Gyurkocza; Florian Hoetzl; Belinda Simoes; Christine Falk; Michael Schleuning; Georg Ledderose
Tolerance and chimerism.
Transplantation 2003;75(9 Suppl):26S-31S.
2003: Hans-Jochem Kolb; Christoph Schmid; Xiao Chen; Anja Woiciechowski; Marie Roskrow; Martin Weber; Wolfgang Guenther; Georg Ledderose; Michael Schleuning
Adoptive immunotherapy in chimeras with donor lymphocytes.
Acta haematologica 2003;110(2-3):110-20.
2002: C Schmid; Martin Weisser; Georg Ledderose; OJ Stötzer; Michael Schleuning; Hans-Jochem Kolb
[Dose-reduced conditioning before allogeneic stem cell transplantation: principles, clinical protocols and preliminary results].
Deutsche medizinische Wochenschrift (1946) 2002;127(42):2186-92.
2002: Hans-Jochem Kolb; Ch Schmid; Martin Weisser; Markus Pihusch; Johanna Tischer; Rudolf Pihusch; Oliver J Stoetzer; Georg Ledderose; Michael Schleuning
Cytoreduction, DLI, or mobilized peripheral blood progenitors.
Annals of hematology 2002;81 Suppl 2():S30-3.
2002: Michael Schleuning; Oliver J Stoetzer; Christine Waterhouse; Marcus Schlemmer; Georg Ledderose; Hans-Jochem Kolb
Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease.
Experimental hematology 2002;30(1):7-10.
2001: Michael Schleuning; Wolfgang Hiddemann
[New molecular therapy options in hematology and oncology, exemplified by STI571].
Der Internist 2001;42(12):1591-7.
2001: OJ Stötzer; Michael Schleuning; Georg Ledderose; Wolfgang Hiddemann; Hans-Jochem Kolb
[Allogeneic transplantation in malignant lymphoma].
Deutsche medizinische Wochenschrift (1946) 2001;126(39):1062-9.
1999: Michael Schleuning; Gabriele Jäger; Ernst Holler; W Hill; C Thomssen; Claudio Denzlinger; T Lorenz; Georg Ledderose; W Wilmanns; Hans-Jochem Kolb
Human parvovirus B19-associated disease in bone marrow transplantation.
Infection 1999;27(2):114-7.
1999: Michael Schleuning; J Mittermüller; Hans-Jochem Kolb
Bcr-abl protein detection in peripheral blood mononuclear cells for follow-up of chronic myelogenous leukaemia patients.
European journal of haematology 1999;62(3):149-54.
1998: Claudio S Padovan; Tarek A Yousry; Michael Schleuning; Ernst Holler; Hans-Jochem Kolb; Andreas Straube
Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation.
Annals of neurology 1998;43(5):627-33.
1995: Markus Böck; Michael Schleuning; Marcell U Heim; W Mempel
Cryopreservation of human platelets with dimethyl sulfoxide: changes in biochemistry and cell function.
Transfusion 1995;35(11):921-4.
1995: Ernst Holler; Hans-Jochem Kolb; J Mittermüller; M Kaul; Georg Ledderose; Thomas Duell; B Seeber; Michael Schleuning; R Hintermeier-Knabe; B Ertl
Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F).
Blood 1995;86(3):890-9.
1994: Michael Schleuning; V Brumme; W Wilmanns
Inhibition of cyclosporin A/FK506 resistant, lymphokine-induced T-cell activation by phenothiazine derivatives.
Naunyn-Schmiedeberg's archives of pharmacology 1994;350(1):100-3.
1994: Michael Schleuning; C Thomssen; Hans-Jochem Kolb; H J Sauer; W Wilmanns
Treatment of refractory severe aplastic anemia with granulocyte colony stimulating factor and interleukin 3.
American journal of hematology 1994;46(3):250-1.
1994: Markus Böck; Marcell U Heim; Michael Schleuning; B Kempter; W Mempel
[Previous activation of platelets during storage: possible causes].
Beiträge zur Infusionstherapie und Transfusionsmedizin = Contributions to infusion therapy and transfusion medicine 1994;32():81-3.
1994: Michael Schleuning; Markus Böck; W Mempel
Complement activation during storage of single-donor platelet concentrates.
Vox sanguinis 1994;67(2):144-8.
1993: Michael Schleuning; C Thomssen; Hans-Jochem Kolb; H Sauer; W Wilmanns
[61-year-old patient with hemorrhagic diathesis and fatigue].
Der Internist 1993;34(12):1141-5.
1993: Michael Schleuning; V Brumme; W Wilmanns
Growth inhibition of human leukemic cell lines by the phenothiazine derivative fluphenazine.
Anticancer research 1993;13(3):599-602.
1993: Markus Böck; A Glaser; A Pfosser; Michael Schleuning; Marcell U Heim; W Mempel
Storage of single-donor platelet concentrates: metabolic and functional changes.
Transfusion 1993;33(4):311-5.
1993: U Vehling-Kaiser; Michael Schleuning; Georg Kueffer; Karl-Walter Jauch; E Kaiser
Lusorian artery lesion as rare cause of severe upper gastrointestinal tract bleeding.
Digestive diseases and sciences 1993;38(1):178-80.
1993: Arthur Gerl; C Clemm; Michael Schleuning; W Wilmanns
Fatal cerebrovascular accident associated with chemotherapy for testicular cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(8):1220-1.
1992: Michael Schleuning; H Utz; M Heim; W Mempel
Effects of leukocyte depletion on the formation of anaphylatoxins in stored whole blood.
Infusionstherapie und Transfusionsmedizin 1992;19(5):242-4.
1992: Michael Schleuning; M Schmid-Haslbeck; H Utz; Marianne Jochum; M Heim; W Mempel; W Wilmanns
Complement activation during storage of blood under normal blood bank conditions. Effects of proteinase inhibitors and leukocyte depletion.
Blood 1992;79(11):3071-5.
1992: Marcell U Heim; Markus Böck; Hans-Jochem Kolb; Michael Schleuning; W Mempel
Intravenous anti-D gammaglobulin for the prevention of rhesus isoimmunization caused by platelet transfusions in patients with malignant diseases.
Vox sanguinis 1992;62(3):165-8.
1992: Michael Schleuning; H Utz; M Heim; W Mempel
Decreased formation of the complement component C4A in leukocyte-depleted stored whole blood.
Beiträge zur Infusionstherapie = Contributions to infusion therapy 1992;30():182-5.
1990: Michael Schleuning; R Munker
Tumor necrosis factor: an update on basic research and clinical applications.
Klinische Wochenschrift 1990;68(17):841-6.
1988: Marcell U Heim; Michael Schleuning; R Eckstein; Dieter Huhn; W Siegert; C Clemm; Georg Ledderose; Hans-Jochem Kolb; W Wilmanns; W Mempel
Rh antibodies against the pretransplant red cells following Rh-incompatible bone marrow transplantation.
Transfusion 1988;28(3):272-5.
1987: Michael Schleuning; C Clemm
Chromosomal aberrations in a newborn whose mother received cytotoxic treatment during pregnancy.
The New England journal of medicine 1987;317(26):1666-7.